"Since 1972, patients from across Indiana and throughout the United States come to the Indiana Hand to Shoulder Center for unparalleled orthopedic care for upper extremity conditions and injuries. Our goal is to help our patients relieve their pain and regain function. We always explore conservative treatment first and consider surgery only if necessary. Our highly-skilled, multidisciplinary group specializes in diagnosing and treating the entire spectrum of disorders affecting bones, nerves, tendons, joints, ligaments, and other soft tissues in shoulders, elbows, wrists, and hands. Begin your recovery today with complete care from our world-renowned group of hand surgeons, advanced practice providers, and world-class hand therapists."

During the past decade, Indiana Hand to Shoulder Center conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 9 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Indiana Hand to Shoulder Center" #1 sponsor was "Endo Pharmaceuticals" with 11 trials, followed by "Axogen Corporation" with 3 trials sponsored, "Indiana Hand to Shoulder Center" with 3 trials sponsored, "Biomet Orthopedics, LLC" with 1 trials sponsored and "Cartiva, Inc." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Indiana Hand to Shoulder Center" #1 collaborator was "Stony Brook University" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Indiana Hand to Shoulder Center" are "Dupuytren's Contracture" (5 trials), "Dupuytren's Disease" (4 trials), "Osteoarthritis" (3 trials), "Adhesive Capsulitis" (2 trials) and "Advanced Dupuytren's Disease" (2 trials). Many other conditions were trialed in "Indiana Hand to Shoulder Center" in a lesser frequency.

Most popular intervention types in "Indiana Hand to Shoulder Center" are "Biological" (12 trials), "Device" (4 trials), "Other" (4 trials), "Combination Product" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Collagenase clostridium histolyticum" (2 trials), "collagenase clostridium histolyticum" (2 trials), "AA4500" (1 trials) and "AA4500 0.29 mg/1 mL" (1 trials). Other intervention names were less common.

The vast majority of trials in "Indiana Hand to Shoulder Center" are 22 trials for "All" genders.

Currently, there are NaN active trials in "Indiana Hand to Shoulder Center". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Indiana Hand to Shoulder Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Indiana Hand to Shoulder Center, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 2 trials that are defined as “Not Applicable".